Literature DB >> 33364235

RAB39B Deficiency Impairs Learning and Memory Partially Through Compromising Autophagy.

Mengxi Niu1,2, Naizhen Zheng2, Zijie Wang3, Yue Gao2, Xianghua Luo2, Zhicai Chen2, Xing Fu2, Yanyan Wang1, Ting Wang2, Manqing Liu1, Tingting Yao2, Peijie Yao2, Jian Meng2, Yunqiang Zhou2, Yunlong Ge3, Zhanxiang Wang4, Qilin Ma1, Huaxi Xu2, Yun-Wu Zhang1,2.   

Abstract

RAB39B is located on the X chromosome and encodes the RAB39B protein that belongs to the RAB family. Mutations in RAB39B are known to be associated with X-linked intellectual disability (XLID), Parkinson's disease, and autism. However, the patho/physiological functions of RAB39B remain largely unknown. In the present study, we established Rab39b knockout (KO) mice, which exhibited overall normal birth rate and morphologies as wild type mice. However, Rab39b deficiency led to reduced anxiety and impaired learning and memory in 2 months old mice. Deletion of Rab39b resulted in impairments of synaptic structures and functions, with reductions in NMDA receptors in the postsynaptic density (PSD). RAB39B deficiency also compromised autophagic flux at basal level, which could be overridden by rapamycin-induced autophagy activation. Further, treatment with rapamycin partially rescued impaired memory and synaptic plasticity in Rab39b KO mice, without affecting the PSD distribution of NMDA receptors. Together, these results suggest that RAB39B plays an important role in regulating both autophagy and synapse formation, and that targeting autophagy may have potential for treating XLID caused by RAB39B loss-of-function mutations.
Copyright © 2020 Niu, Zheng, Wang, Gao, Luo, Chen, Fu, Wang, Wang, Liu, Yao, Yao, Meng, Zhou, Ge, Wang, Ma, Xu and Zhang.

Entities:  

Keywords:  NMDA receptors; RAB39B; autophagy; learning and memory; rapamycin

Year:  2020        PMID: 33364235      PMCID: PMC7753041          DOI: 10.3389/fcell.2020.598622

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  7 in total

1.  Clinical characterization of a novel RAB39B nonstop mutation in a family with ASD and severe ID causing RAB39B downregulation and study of a Rab39b knock down mouse model.

Authors:  Maria Lidia Mignogna; Romina Ficarella; Susanna Gelmini; Lucia Marzulli; Emanuela Ponzi; Alessandra Gabellone; Antonia Peschechera; Massino Alessio; Lucia Margari; Mattia Gentile; Patrizia D'Adamo
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

2.  Rab GTPases in Parkinson's disease: a primer.

Authors:  Antonio Jesús Lara Ordóñez; Rachel Fasiczka; Yahaira Naaldijk; Sabine Hilfiker
Journal:  Essays Biochem       Date:  2021-12-22       Impact factor: 8.000

Review 3.  Emerging Mechanisms Underpinning Neurophysiological Impairments in C9ORF72 Repeat Expansion-Mediated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.

Authors:  Iris-Stefania Pasniceanu; Manpreet Singh Atwal; Cleide Dos Santos Souza; Laura Ferraiuolo; Matthew R Livesey
Journal:  Front Cell Neurosci       Date:  2021-12-15       Impact factor: 5.505

Review 4.  The Role of Rab Proteins in Parkinson's Disease Synaptopathy.

Authors:  Arianna Bellucci; Francesca Longhena; Maria Grazia Spillantini
Journal:  Biomedicines       Date:  2022-08-10

5.  RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.

Authors:  Cong Xu; Ting Liang; Jing Liu; Yunfeng Fu
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

6.  Differences in the Autophagy Response to Hypoxia in the Hippocampus and Neocortex of Rats.

Authors:  Anna Churilova; Tatiana Zachepilo; Ksenia Baranova; Elena Rybnikova
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

7.  RAB39B-mediated trafficking of the GluA2-AMPAR subunit controls dendritic spine maturation and intellectual disability-related behaviour.

Authors:  Maria Lidia Mignogna; Stefano Musardo; Giulia Ranieri; Susanna Gelmini; Pedro Espinosa; Paolo Marra; Sara Belloli; Valentina Murtaj; Rosa Maria Moresco; Camilla Bellone; Patrizia D'Adamo
Journal:  Mol Psychiatry       Date:  2021-05-25       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.